• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Association of [3H]zacopride with 5-HT3 binding sites.

作者信息

Pinkus L M, Sarbin N S, Barefoot D S, Gordon J C

机构信息

Department of Molecular Biology, A.H. Robins Research Laboratories, Richmond, Virginia 23261-6609.

出版信息

Eur J Pharmacol. 1989 Sep 22;168(3):355-62. doi: 10.1016/0014-2999(89)90797-8.

DOI:10.1016/0014-2999(89)90797-8
PMID:2583241
Abstract

An assay was developed for [3H]zacopride binding to 5-HT3 specific sites in membranes from rabbit ileum muscularis. The binding was rapid, saturable, reversible, salt-insensitive, unaffected by pH between 6.5 and 9.5, and of high affinity (apparent KD = 0.65 +/- 0.15 nM). ICS 205-930, a potent 5-HT3 antagonist that inhibited competitively, was utilized to define 5-HT3 specific binding. Other 5-HT3 antagonists and agonists, although exhibiting marked differences in potency, were also effective inhibitors; whereas, antagonists of other classes of serotonin receptors, guanyl nucleotides and numerous receptor-specific ligands, including peptide hormones, were inactive. Vagus nerve exhibited the greatest amount of 5-HT3 specific binding amongst rabbit tissues and virtually all of the [3H]zacopride was bound to 5-HT3 binding sites. In rabbit, rat and ferret a fairly uniform distribution of 5-HT3 binding sites was observed along the muscularis of the small bowel. [3H]Zacopride is a high-affinity ligand for detecting 5-HT3 binding sites and rabbit small bowel muscularis membranes are a sensitive system for evaluating the potency of 5-HT3 antagonists or agonists.

摘要

相似文献

1
Association of [3H]zacopride with 5-HT3 binding sites.
Eur J Pharmacol. 1989 Sep 22;168(3):355-62. doi: 10.1016/0014-2999(89)90797-8.
2
[3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.[3H]扎考必利与部分纯化的兔肠神经元膜上的5-羟色胺3位点的结合。
J Pharmacol Exp Ther. 1989 Dec;251(3):962-8.
3
Antagonism of [3H]zacopride binding to 5-HT3 recognition sites by its (R) and (S) enantiomers.
Eur J Pharmacol. 1990 Apr 10;179(1-2):231-5. doi: 10.1016/0014-2999(90)90425-6.
4
Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.脑及其他组织中(R)-扎考必利非5-HT3高亲和力“R”结合位点的表征
Eur J Pharmacol. 1993 Sep 15;247(1):45-56. doi: 10.1016/0922-4106(93)90136-w.
5
[3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
J Pharm Pharmacol. 1988 Aug;40(8):548-51. doi: 10.1111/j.2042-7158.1988.tb05300.x.
6
Solubilization of a 5-HT3 binding site from rabbit small bowel muscularis membranes.
Eur J Pharmacol. 1990 Jun 12;188(6):313-9. doi: 10.1016/0922-4106(90)90191-y.
7
Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.用[3H]-(S)-扎考必利和[3H]格拉司琼标记的NG108-15神经母细胞瘤-胶质瘤细胞中5-HT3受体识别位点激动剂的差异结合特性
Biochem Pharmacol. 1993 May 25;45(10):2155-8. doi: 10.1016/0006-2952(93)90030-z.
8
Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.从NG 108-15神经母细胞瘤-胶质瘤细胞膜中溶解出来的5-羟色胺5-HT3结合位点的物理化学性质。
J Neurochem. 1990 Nov;55(5):1526-36. doi: 10.1111/j.1471-4159.1990.tb04935.x.
9
Nerve growth factor induces 5-HT3 recognition sites in rat pheochromocytoma (PC12) cells.
Life Sci. 1990;46(20):1435-42. doi: 10.1016/0024-3205(90)90459-5.
10
Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Biochem Pharmacol. 1990 Oct 1;40(7):1541-50. doi: 10.1016/0006-2952(90)90452-q.

引用本文的文献

1
5-hydroxytryptamine strongly inhibits fluid secretion in guinea pig pancreatic duct cells.5-羟色胺强烈抑制豚鼠胰腺导管细胞中的液体分泌。
J Clin Invest. 2001 Sep;108(5):749-56. doi: 10.1172/JCI12312.
2
Characterization of the binding of [3H]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes.[3H] -氯苯丙哌嗪与豚鼠大脑皮层膜中组胺H3受体结合的特性研究。
Br J Pharmacol. 1999 Oct;128(4):881-90. doi: 10.1038/sj.bjp.0702860.
3
The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.
血清素在精神分裂症中的作用:中枢神经系统中血清素受体的命名、分布及变化概述
Psychopharmacology (Berl). 1993;112(1 Suppl):S5-15. doi: 10.1007/BF02245003.
4
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.强效选择性拮抗剂RS 25259-197与5-HT3受体在体外的相互作用。
Br J Pharmacol. 1995 Feb;114(4):851-9. doi: 10.1111/j.1476-5381.1995.tb13282.x.
5
Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.雪貂脑干中5-羟色胺3型受体识别位点的拓扑分布。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):17-21. doi: 10.1007/BF00178966.
6
Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.介导豚鼠离体回肠收缩的5-羟色胺3型和“非典型”5-羟色胺受体的特性研究
Br J Pharmacol. 1990 Nov;101(3):513-20. doi: 10.1111/j.1476-5381.1990.tb14113.x.
7
Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.5-羟色胺3受体拮抗剂对纳洛酮诱发的阿片类物质戒断行为指标的影响。
Psychopharmacology (Berl). 1991;105(3):322-8. doi: 10.1007/BF02244425.
8
Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.激动剂与经结构多样的放射性配体标记的大鼠内嗅皮质中5-HT3受体识别位点的相互作用。
Br J Pharmacol. 1992 Feb;105(2):500-4. doi: 10.1111/j.1476-5381.1992.tb14283.x.
9
Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.大鼠胃肠道中5-羟色胺3型(5-HT3)识别位点的鉴定与分布
Br J Pharmacol. 1992 Jul;106(3):693-6. doi: 10.1111/j.1476-5381.1992.tb14396.x.
10
Neuropharmacology of emesis in relation to clinical response.与临床反应相关的呕吐神经药理学
Br J Cancer Suppl. 1992 Dec;19:S2-7; discussion S7-8.